Study Ignites Debate on New Anticoagulant

• Autores: Mike Mitka
• Localización: JAMA: the journal of the American Medical Association, ISSN 0098-7484, Vol. 309, Nº. 17, 2013 (Ejemplar dedicado a: Child Health), págs. 1763-1764
• Idioma: inglés
• Texto completo no disponible (Saber más ...)
• Resumen

  • San Francisco� Researchers claim that an experimental anticlotting drug that failed to demonstrate benefit in 2 previous studies showed positive results in a new study. They said the experimental drug, cangrelor, may offer another option for reducing periprocedural complications from percutaneous coronary intervention (PCI). But others are not so sure.